DIN 02323052 — INSPRA 25 MG
INSPRA is a tablet of Eplerenone marketed by BGP PHARMA ULC. The full Eplerenone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02323052
- Brand name
- INSPRA
- Active ingredient
- Eplerenone
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BGP PHARMA ULC
- Health Canada status
- MARKETED
- Drug class
- Selective aldosterone (mineralocorticoid receptor) antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Eplerenone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02323060 | INSPRA | 50 MG | TABLET | BGP PHARMA ULC | MARKETED |
| 02543389 | JAMP EPLERENONE | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02543397 | JAMP EPLERENONE | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02471442 | MINT-EPLERENONE | 25 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02471450 | MINT-EPLERENONE | 50 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |